KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 98 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $363,571 | +8.3% | 37,754 | +1.2% | 0.05% | 0.0% |
| Q2 2023 | $335,754 | +14.4% | 37,306 | -0.1% | 0.05% | +15.0% |
| Q1 2023 | $293,500 | -7.7% | 37,341 | -20.6% | 0.04% | -21.6% |
| Q4 2022 | $318,017 | +128.8% | 47,044 | +233.3% | 0.05% | +325.0% |
| Q2 2022 | $139,000 | -29.8% | 14,113 | -13.5% | 0.01% | -7.7% |
| Q2 2020 | $198,000 | +33.8% | 16,325 | -15.4% | 0.01% | +8.3% |
| Q1 2020 | $148,000 | -65.3% | 19,300 | -19.4% | 0.01% | -53.8% |
| Q4 2019 | $427,000 | – | 23,952 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 719,937 | $6,697,459 | 5.56% |
| TCG Crossover Management, LLC | 3,395,495 | $22,953,546 | 4.05% |
| VR Adviser, LLC | 2,916,667 | $19,716,669 | 3.32% |
| TANG CAPITAL MANAGEMENT LLC | 3,196,446 | $21,607,975 | 3.14% |
| Prosight Management, LP | 621,667 | $4,202,469 | 2.29% |
| Opaleye Management Inc. | 923,200 | $6,240,832 | 2.17% |
| GREAT POINT PARTNERS LLC | 1,055,801 | $7,137,215 | 1.40% |
| Frazier Life Sciences Management, L.P. | 3,238,859 | $21,894,687 | 1.36% |
| DAFNA Capital Management LLC | 616,032 | $4,164,376 | 1.17% |
| Vivo Capital, LLC | 856,008 | $5,787 | 0.67% |